Spruce Biosciences, Inc. (NASDAQ:SPRB) Q1 2023 Earnings Call Transcript April 15, 2025
Spruce Biosciences, Inc. misses on earnings expectations. Reported EPS is $-0.57 EPS, expectations were $-0.21.
Operator: Welcome to the Spruce Biosciences Investor Call [Operator Instructions]. Please note, this conference call is being recorded. I’ll now turn the floor over to Samir Gharib, President and CFO of Spruce Biosciences. Samir, the floor is yours.
Samir Gharib: Thank you, operator. And thank...
